» Articles » PMID: 38106479

The Impact of COVID-19 on Health Anxiety and Perceived Stress Among Persons with IBD: A Population-representative Study

Abstract

Background: The Corona Virus Immune Disease-2019 (COVID-19) pandemic has broadly impacted the mental health of individuals worldwide, especially with restrictions including social distancing and quarantining. Persons with IBD are at increased risk of mental health disorders. The aim was to understand how the COVID-19 pandemic affected adults with a chronic health issue, inflammatory bowel disease (IBD), using a population-based sample.

Methods: A survey study in Manitoba was conducted during the second COVID-19 wave in autumn 2020. We assessed proportions of health anxiety and perceived stress using validated measures, as well as stressors during the COVID-19 pandemic. We used univariable and multivariable logistic regression analysis to assess predictors of perceived stress and health anxiety.

Results: A total of 1,384 (47.1%) persons responded, with a mean age of 58.0, and 46.9% had Crohn's disease. Almost three quarters (73.7%) had increased stress, with 37.7% having increased stress about their IBD, and 33.6% worried about their IBD worsening. 46.0% felt increased stress about accessing their doctor or nurse, and 56.5% felt they had good access to their gastroenterologist. Elevated stress and health anxiety were seen in 63.5% and 17.2% of respondents, respectively. Younger age and being on immune-modifying therapy (IMT) was predictive of increased health anxiety and stress. Longer IBD duration was associated with decreased stress, including those on IMT.

Conclusion: Persons with IBD reported high rates of stress and health anxiety early in the COVID-19 pandemic, especially among those on IMT. It will be important to determine how this evolved over time and to what extent this impacted on disease course.

References
1.
Stone M, Feng M, Forster E . COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center. Dig Dis Sci. 2021; 67(7):2876-2881. PMC: 8193011. DOI: 10.1007/s10620-021-07095-y. View

2.
Moum K, Moum B, Opheim R . Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic. Scand J Gastroenterol. 2021; 56(5):545-551. DOI: 10.1080/00365521.2021.1901308. View

3.
Xiong J, Lipsitz O, Nasri F, Lui L, Gill H, Phan L . Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020; 277:55-64. PMC: 7413844. DOI: 10.1016/j.jad.2020.08.001. View

4.
El-Gabalawy R, Sommer J . "We Are at Risk Too": The Disparate Mental Health Impacts of the Pandemic on Younger Generations: Nous Sommes Aussi à Risque: Les Effets Disparates de la Pandémie Sur la Santé Mentale des Générations Plus Jeunes. Can J Psychiatry. 2021; 66(7):634-644. PMC: 8239993. DOI: 10.1177/0706743721989162. View

5.
Sehgal P, Ungaro R, Foltz C, Iacoviello B, Dubinsky M, Keefer L . High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020; 27(6):791-796. PMC: 8128407. DOI: 10.1093/ibd/izaa196. View